| |
| |
|
| Insider
Information: |
Weiss Amir |
| Relationship: |
|
| City: |
Tel Aviv |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
33,314 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$460,066 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
33,314 |
|
|
| Total
Value |
$460,066 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Teva Pharmaceutical Industries L... |
TEVA |
|
2024-03-05 |
33,314 |
2022-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,564 |
33,314 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,676 |
29,750 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,179 |
19,074 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,219 |
13,895 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2024-02-01 |
4 |
S |
$12.37 |
$392,955 |
D/D |
(31,766) |
10,676 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2023-08-04 |
4 |
S |
$9.92 |
$19,658 |
D/D |
(1,981) |
42,442 |
0 |
% |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2023-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,564 |
41,204 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2023-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,082 |
37,640 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,219 |
27,777 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2022-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,564 |
24,558 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2022-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,403 |
20,994 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
981 |
18,591 |
0 |
- |
|
| TEVA |
Teva Pharmaceutical Indus... |
Chief Accounting Officer |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,219 |
17,610 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
